Bioharvest Sciences (BHST) Cost of Revenue (2023 - 2025)
Bioharvest Sciences has reported Cost of Revenue over the past 3 years, most recently at $2.2 million for Q4 2025.
- For Q4 2025, Cost of Revenue fell 23.74% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $14.0 million, up 19.59%, while the annual FY2025 figure was $14.0 million, 19.59% up from the prior year.
- Cost of Revenue was $2.2 million for Q4 2025 at Bioharvest Sciences, down from $4.1 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $4.1 million in Q3 2025 and bottomed at $1.6 million in Q2 2023.
- The 3-year median for Cost of Revenue is $2.9 million (2023), against an average of $2.9 million.
- Year-over-year, Cost of Revenue soared 90.15% in 2024 and then dropped 23.74% in 2025.
- Over 3 years, Cost of Revenue stood at $2.9 million in 2023, then rose by 0.14% to $2.9 million in 2024, then dropped by 23.74% to $2.2 million in 2025.
- The last three reported values for Cost of Revenue were $2.2 million (Q4 2025), $4.1 million (Q3 2025), and $4.0 million (Q2 2025) per Business Quant data.